bpc-157 pentadecapeptide derived from gastric juice Frontiers BPC-157 – Mark Hyman, MD

WADA Not currently listed on the WADA Prohibited List

Effects of Madecassoside on activation of NF-B p65 in HK-2 cells NF-B p65 can be activated by p-ERK1/2, moreover, the p-ERK1/2 and increased NF-B p65 in mice kidney were observed after DOX injection in our studies

It is not an FDA-approved drug for systemic therapeutic use

Because these compounds are naturally occurring peptides with restricted patentability, opportunities for intellectual property protection and industry-sponsored development are limitedposing substantial barriers to the resource-intensive clinical investigations required to confirm therapeutic efficacy and long-term safety